Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Published 2019 View Full Article

Authors

Keywords

Familial hypercholesterolemia, PCSK9 mAb, Cardiovascular risk assessment, NNT, SAFEHEART, CTT

Journal

ATHEROSCLEROSIS

Volume 286, Issue -, Pages 40-45

Publisher

Elsevier BV

Online

2019-05-07

DOI

10.1016/j.atherosclerosis.2019.05.003

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started